γδ T-PD-1 Ab Cells in the Treatment of Malignant Meningioma
Clinical trial NCT07172178 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07172178
- Sponsor
- Nanjing Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-15
- Primary completion
- 2028-10-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.